The Julius L. Chambers
BIOMEDICAL/BIOTECHNOLOGY
RESEARCH INSTITUTE

Cardiovascular Research Program

The JLC-BBRI has established a federally-funded research program aimed at understanding the molecular, cellular, environmental, and genetic aspects of cardiovascular function under normal healthy conditions as well during the pathologic insult of injury and/or disease.

Cardiovascular Cells
From: Tulis, D.A. Invited Submission: Novel therapies for cyclic GMP control of vascular smooth muscle growth. American J. Therapeutics (in press), 2007.

Key Personnel